Divis Laboratories Ltd | DIVI - Cash And Equivalent

Stock Price
6,395.50
Daily Change
140.00 2.24%
Monthly
5.61%
Yearly
13.88%
Q1 Forecast
6,171.47

Divis Laboratories Ltd reported INR4.15B in Cash and Equivalent for its fiscal quarter ending in March of 2025.





Cash And Equivalent Change Date
Alaunos Therapeutics USD 1.94M 941K Sep/2025
Aurobindo Pharma INR 88.91B 6.56B Sep/2025
Avita Medical AUD 12.22M 1.83M Jun/2025
Dianthus Therapeutics USD 55.98M 42.75M Sep/2025
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Ionis Pharmaceuticals USD 2.24B 1.94B Sep/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Lupin INR 30.4B 1.02B Sep/2025
Moderna USD 2.6B 1.46B Dec/2025
Organon & Co USD 672M 73M Sep/2025
Revvity USD 919.86M 11.53M Dec/2025
Tectonic Therapeutic USD 268.44M 18.94M Sep/2025
Tilray USD 264.83M 43.16M Jun/2025
Viatris USD 975.3M 408.9M Sep/2025
Xeris Pharmaceuticals USD 91.6M 32.32M Sep/2025